MSB 4.00% $1.17 mesoblast limited

Cell Therapy News/Articles, page-13512

  1. 3,955 Posts.
    lightbulb Created with Sketch. 1355
    I don't think @dachopper is wrong, if anything it could take longer. This is why the FDA have the accelerated approval pathway. It gives access to the therapy for those that are most likely to respond and have very much a unmet medical need.

    By my understanding of the process we should find out before the end of this month.

    Good luck all.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.17
Change
0.045(4.00%)
Mkt cap ! $1.335B
Open High Low Value Volume
$1.13 $1.18 $1.13 $4.980M 4.315M

Buyers (Bids)

No. Vol. Price($)
4 73090 $1.15
 

Sellers (Offers)

Price($) Vol. No.
$1.17 27903 1
View Market Depth
Last trade - 16.10pm 30/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.